The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression

Abstract Background Migraine affects 1.1 billion people globally and is the second leading cause of disability worldwide. In clinical trials, treatment efficacy is evaluated by comparing the differential responses in the treatment and placebo arms. Although placebo response in preventive migraine tr...

Full description

Bibliographic Details
Main Authors: Stewart J. Tepper, Jessica Cirillo, Edward Kim, Gil L’Italien, Julie M. Tweedie, Kunal Lodaya, Dushon Riley, Farah Pathan, Nicholas Antaki, Brian H. Nathanson, Peter McAllister
Format: Article
Language:English
Published: BMC 2023-05-01
Series:The Journal of Headache and Pain
Subjects:
Online Access:https://doi.org/10.1186/s10194-023-01587-0
_version_ 1797822726437601280
author Stewart J. Tepper
Jessica Cirillo
Edward Kim
Gil L’Italien
Julie M. Tweedie
Kunal Lodaya
Dushon Riley
Farah Pathan
Nicholas Antaki
Brian H. Nathanson
Peter McAllister
author_facet Stewart J. Tepper
Jessica Cirillo
Edward Kim
Gil L’Italien
Julie M. Tweedie
Kunal Lodaya
Dushon Riley
Farah Pathan
Nicholas Antaki
Brian H. Nathanson
Peter McAllister
author_sort Stewart J. Tepper
collection DOAJ
description Abstract Background Migraine affects 1.1 billion people globally and is the second leading cause of disability worldwide. In clinical trials, treatment efficacy is evaluated by comparing the differential responses in the treatment and placebo arms. Although placebo response in preventive migraine trials has been studied, there is limited research examining temporal trends. This study evaluates the trend of placebo response over thirty years in migraine prevention trials and investigates the association of potential confounders, such as patient, treatment, and study characteristics on placebo response using meta-analysis with regression. Methods We conducted literature searches from January 1990 to August 2021 in bibliographical databases (PubMed, Cochrane Library, and EMBASE). Studies were selected according to PICOS criteria and included randomized, double-blind, placebo-controlled trials evaluating preventive migraine treatments in adult patients diagnosed with episodic or chronic migraine, with or without aura. The protocol was registered with PROSPERO (CRD42021271732). Migraine efficacy outcomes included were either continuous (e.g., monthly migraine days) or dichotomous (e.g., ≥ 50% responder rate (yes/no)). We assessed the correlation of the change in outcome from baseline in the placebo arm, with the year of publication. The relationship between placebo response and year of publication was also assessed after accounting to confounders. Results A total of 907 studies were identified, and 83 were found eligible. For the continuous outcomes, the change from baseline in mean placebo response showed an increase over the years (rho = 0.32, p = 0.006). The multivariable regression analysis also showed an overall increase in placebo response over the years. The correlation analysis of dichotomous responses showed no significant linear trend between publication year and mean placebo response (rho = 0.08, p = 0.596). Placebo response also varied by route of administration. Conclusion Placebo response increased over the past 30 years in migraine preventive trials. This phenomenon should be considered when designing clinical trials and conducting meta-analyses.
first_indexed 2024-03-13T10:13:23Z
format Article
id doaj.art-3e58907b2f604a08a99a67903cab2933
institution Directory Open Access Journal
issn 1129-2377
language English
last_indexed 2024-03-13T10:13:23Z
publishDate 2023-05-01
publisher BMC
record_format Article
series The Journal of Headache and Pain
spelling doaj.art-3e58907b2f604a08a99a67903cab29332023-05-21T11:22:03ZengBMCThe Journal of Headache and Pain1129-23772023-05-0124111810.1186/s10194-023-01587-0The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regressionStewart J. Tepper0Jessica Cirillo1Edward Kim2Gil L’Italien3Julie M. Tweedie4Kunal Lodaya5Dushon Riley6Farah Pathan7Nicholas Antaki8Brian H. Nathanson9Peter McAllister10Geisel School of Medicine at Dartmouth, Dartmouth Headache ClinicBiohaven PharmaceuticalsBiohaven PharmaceuticalsBiohaven PharmaceuticalsBiohaven PharmaceuticalsBoston Strategic Partners IncBoston Strategic Partners IncBoston Strategic Partners IncBoston Strategic Partners IncOptiStatim, LLCNew England Institute for Neurology and HeadacheAbstract Background Migraine affects 1.1 billion people globally and is the second leading cause of disability worldwide. In clinical trials, treatment efficacy is evaluated by comparing the differential responses in the treatment and placebo arms. Although placebo response in preventive migraine trials has been studied, there is limited research examining temporal trends. This study evaluates the trend of placebo response over thirty years in migraine prevention trials and investigates the association of potential confounders, such as patient, treatment, and study characteristics on placebo response using meta-analysis with regression. Methods We conducted literature searches from January 1990 to August 2021 in bibliographical databases (PubMed, Cochrane Library, and EMBASE). Studies were selected according to PICOS criteria and included randomized, double-blind, placebo-controlled trials evaluating preventive migraine treatments in adult patients diagnosed with episodic or chronic migraine, with or without aura. The protocol was registered with PROSPERO (CRD42021271732). Migraine efficacy outcomes included were either continuous (e.g., monthly migraine days) or dichotomous (e.g., ≥ 50% responder rate (yes/no)). We assessed the correlation of the change in outcome from baseline in the placebo arm, with the year of publication. The relationship between placebo response and year of publication was also assessed after accounting to confounders. Results A total of 907 studies were identified, and 83 were found eligible. For the continuous outcomes, the change from baseline in mean placebo response showed an increase over the years (rho = 0.32, p = 0.006). The multivariable regression analysis also showed an overall increase in placebo response over the years. The correlation analysis of dichotomous responses showed no significant linear trend between publication year and mean placebo response (rho = 0.08, p = 0.596). Placebo response also varied by route of administration. Conclusion Placebo response increased over the past 30 years in migraine preventive trials. This phenomenon should be considered when designing clinical trials and conducting meta-analyses.https://doi.org/10.1186/s10194-023-01587-0MigrainePlacebo responsePreventive treatmentTemporal trendMeta-analysisSystematic literature review
spellingShingle Stewart J. Tepper
Jessica Cirillo
Edward Kim
Gil L’Italien
Julie M. Tweedie
Kunal Lodaya
Dushon Riley
Farah Pathan
Nicholas Antaki
Brian H. Nathanson
Peter McAllister
The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression
The Journal of Headache and Pain
Migraine
Placebo response
Preventive treatment
Temporal trend
Meta-analysis
Systematic literature review
title The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression
title_full The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression
title_fullStr The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression
title_full_unstemmed The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression
title_short The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression
title_sort temporal trend of placebo response in migraine prevention from 1990 to 2021 a systematic literature review and meta analysis with regression
topic Migraine
Placebo response
Preventive treatment
Temporal trend
Meta-analysis
Systematic literature review
url https://doi.org/10.1186/s10194-023-01587-0
work_keys_str_mv AT stewartjtepper thetemporaltrendofplaceboresponseinmigrainepreventionfrom1990to2021asystematicliteraturereviewandmetaanalysiswithregression
AT jessicacirillo thetemporaltrendofplaceboresponseinmigrainepreventionfrom1990to2021asystematicliteraturereviewandmetaanalysiswithregression
AT edwardkim thetemporaltrendofplaceboresponseinmigrainepreventionfrom1990to2021asystematicliteraturereviewandmetaanalysiswithregression
AT gillitalien thetemporaltrendofplaceboresponseinmigrainepreventionfrom1990to2021asystematicliteraturereviewandmetaanalysiswithregression
AT juliemtweedie thetemporaltrendofplaceboresponseinmigrainepreventionfrom1990to2021asystematicliteraturereviewandmetaanalysiswithregression
AT kunallodaya thetemporaltrendofplaceboresponseinmigrainepreventionfrom1990to2021asystematicliteraturereviewandmetaanalysiswithregression
AT dushonriley thetemporaltrendofplaceboresponseinmigrainepreventionfrom1990to2021asystematicliteraturereviewandmetaanalysiswithregression
AT farahpathan thetemporaltrendofplaceboresponseinmigrainepreventionfrom1990to2021asystematicliteraturereviewandmetaanalysiswithregression
AT nicholasantaki thetemporaltrendofplaceboresponseinmigrainepreventionfrom1990to2021asystematicliteraturereviewandmetaanalysiswithregression
AT brianhnathanson thetemporaltrendofplaceboresponseinmigrainepreventionfrom1990to2021asystematicliteraturereviewandmetaanalysiswithregression
AT petermcallister thetemporaltrendofplaceboresponseinmigrainepreventionfrom1990to2021asystematicliteraturereviewandmetaanalysiswithregression
AT stewartjtepper temporaltrendofplaceboresponseinmigrainepreventionfrom1990to2021asystematicliteraturereviewandmetaanalysiswithregression
AT jessicacirillo temporaltrendofplaceboresponseinmigrainepreventionfrom1990to2021asystematicliteraturereviewandmetaanalysiswithregression
AT edwardkim temporaltrendofplaceboresponseinmigrainepreventionfrom1990to2021asystematicliteraturereviewandmetaanalysiswithregression
AT gillitalien temporaltrendofplaceboresponseinmigrainepreventionfrom1990to2021asystematicliteraturereviewandmetaanalysiswithregression
AT juliemtweedie temporaltrendofplaceboresponseinmigrainepreventionfrom1990to2021asystematicliteraturereviewandmetaanalysiswithregression
AT kunallodaya temporaltrendofplaceboresponseinmigrainepreventionfrom1990to2021asystematicliteraturereviewandmetaanalysiswithregression
AT dushonriley temporaltrendofplaceboresponseinmigrainepreventionfrom1990to2021asystematicliteraturereviewandmetaanalysiswithregression
AT farahpathan temporaltrendofplaceboresponseinmigrainepreventionfrom1990to2021asystematicliteraturereviewandmetaanalysiswithregression
AT nicholasantaki temporaltrendofplaceboresponseinmigrainepreventionfrom1990to2021asystematicliteraturereviewandmetaanalysiswithregression
AT brianhnathanson temporaltrendofplaceboresponseinmigrainepreventionfrom1990to2021asystematicliteraturereviewandmetaanalysiswithregression
AT petermcallister temporaltrendofplaceboresponseinmigrainepreventionfrom1990to2021asystematicliteraturereviewandmetaanalysiswithregression